Tupper Colleen's Form 4 filing
Collegium Pharmaceutical, Inc (COLL) · filed Nov 7, 2025
- Accession no.
- 0001862082-25-000004
- Filed
- Nov 7, 2025
- Trade date
- Nov 6, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions. Open-market sales total $1.22M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tupper ColleenCIK 0001862082 | Officer (EVP & Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 6, 2025 | Common Stock | SSaleDisposed | −25,142 | $40.38 | −$1,015,233.96 | 131,525 | Direct | |
| Nov 6, 2025 | Common Stock | SSaleDisposed | −4,858 | $41.28 | −$200,538.24 | 126,667 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.